The post BTC Leverage Builds Near $120K, Big Test Ahead appeared on BitcoinEthereumNews.com. Key Insights: Heavy leverage builds at $118K–$120K, turning the zone into Bitcoin’s next critical resistance test. Rejection from point of interest with delta divergences suggests cooling momentum after the recent FOMC-driven spike. Support levels at $114K–$115K may attract buyers if BTC fails to break above $120K. BTC Leverage Builds Near $120K, Big Test Ahead Bitcoin was trading around $117,099, with daily volume close to $59.1 billion. The price has seen a marginal 0.01% gain over the past 24 hours and a 2% rise in the past week. Data shared by Killa points to heavy leverage building between $118,000 and $120,000. Heatmap charts back this up, showing dense liquidity bands in that zone. Such clusters of orders often act as magnets for price action, as markets tend to move where liquidity is stacked. Price Action Around the POI Analysis from JoelXBT highlights how Bitcoin tapped into a key point of interest (POI) during the recent FOMC-driven spike. This move coincided with what was called the “zone of max delta pain”, a level where aggressive volume left imbalances in order flow. Source: JoelXBT /X Following the test of this area, BTC faced rejection and began to pull back. Delta indicators revealed extended divergences, with price rising while buyer strength weakened. That mismatch suggests demand failed to keep up with the pace of the rally, leaving room for short-term cooling. Resistance and Support Levels The $118K–$120K range now stands as a major resistance band. A clean move through $120K could force leveraged shorts to cover, potentially driving further upside. On the downside, smaller liquidity clusters are visible near $114K–$115K. If rejection holds at the top, these levels are likely to act as the first supports where buyers may attempt to step in. Market Outlook Bitcoin’s next decisive move will likely form around the… The post BTC Leverage Builds Near $120K, Big Test Ahead appeared on BitcoinEthereumNews.com. Key Insights: Heavy leverage builds at $118K–$120K, turning the zone into Bitcoin’s next critical resistance test. Rejection from point of interest with delta divergences suggests cooling momentum after the recent FOMC-driven spike. Support levels at $114K–$115K may attract buyers if BTC fails to break above $120K. BTC Leverage Builds Near $120K, Big Test Ahead Bitcoin was trading around $117,099, with daily volume close to $59.1 billion. The price has seen a marginal 0.01% gain over the past 24 hours and a 2% rise in the past week. Data shared by Killa points to heavy leverage building between $118,000 and $120,000. Heatmap charts back this up, showing dense liquidity bands in that zone. Such clusters of orders often act as magnets for price action, as markets tend to move where liquidity is stacked. Price Action Around the POI Analysis from JoelXBT highlights how Bitcoin tapped into a key point of interest (POI) during the recent FOMC-driven spike. This move coincided with what was called the “zone of max delta pain”, a level where aggressive volume left imbalances in order flow. Source: JoelXBT /X Following the test of this area, BTC faced rejection and began to pull back. Delta indicators revealed extended divergences, with price rising while buyer strength weakened. That mismatch suggests demand failed to keep up with the pace of the rally, leaving room for short-term cooling. Resistance and Support Levels The $118K–$120K range now stands as a major resistance band. A clean move through $120K could force leveraged shorts to cover, potentially driving further upside. On the downside, smaller liquidity clusters are visible near $114K–$115K. If rejection holds at the top, these levels are likely to act as the first supports where buyers may attempt to step in. Market Outlook Bitcoin’s next decisive move will likely form around the…

BTC Leverage Builds Near $120K, Big Test Ahead

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Insights:

  • Heavy leverage builds at $118K–$120K, turning the zone into Bitcoin’s next critical resistance test.
  • Rejection from point of interest with delta divergences suggests cooling momentum after the recent FOMC-driven spike.
  • Support levels at $114K–$115K may attract buyers if BTC fails to break above $120K.
BTC Leverage Builds Near $120K, Big Test Ahead

Bitcoin was trading around $117,099, with daily volume close to $59.1 billion. The price has seen a marginal 0.01% gain over the past 24 hours and a 2% rise in the past week.

Data shared by Killa points to heavy leverage building between $118,000 and $120,000. Heatmap charts back this up, showing dense liquidity bands in that zone. Such clusters of orders often act as magnets for price action, as markets tend to move where liquidity is stacked.

Price Action Around the POI

Analysis from JoelXBT highlights how Bitcoin tapped into a key point of interest (POI) during the recent FOMC-driven spike. This move coincided with what was called the “zone of max delta pain”, a level where aggressive volume left imbalances in order flow.

Source: JoelXBT /X

Following the test of this area, BTC faced rejection and began to pull back. Delta indicators revealed extended divergences, with price rising while buyer strength weakened. That mismatch suggests demand failed to keep up with the pace of the rally, leaving room for short-term cooling.

Resistance and Support Levels

The $118K–$120K range now stands as a major resistance band. A clean move through $120K could force leveraged shorts to cover, potentially driving further upside.

On the downside, smaller liquidity clusters are visible near $114K–$115K. If rejection holds at the top, these levels are likely to act as the first supports where buyers may attempt to step in.

Market Outlook

Bitcoin’s next decisive move will likely form around the heavy positioning near $120K. Traders are closely watching to see if the buildup of leverage there will cap the rally or fuel a breakout.

As noted, “Price tapped right into our POI, lining up with the zone of max delta pain.” For now, the market remains caught between leverage-heavy resistance above and layered support below, setting the stage for volatility before a clearer direction emerges.

DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.

Source: https://coincu.com/analysis/btc-leverage-builds-near-120k/

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.332
$1.332$1.332
-1.47%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Unprecedented US Military Operation Shakes Middle East Security

Unprecedented US Military Operation Shakes Middle East Security

The post Unprecedented US Military Operation Shakes Middle East Security appeared on BitcoinEthereumNews.com. Trump Kharg Island Airstrike: Unprecedented US Military
Share
BitcoinEthereumNews2026/03/14 07:25
Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

The post Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme appeared on BitcoinEthereumNews.com. Michael Saylor has responded sharply
Share
BitcoinEthereumNews2026/03/14 07:22
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11